Fake news narrative crushed: Trump doesn’t own stake in anti-viral drug

The media keeps trying, and they keep failing.

Their most recent atrocity took the form of a blatantly false narrative that President Trump had a financial stake in the company that produces hydroxychloroquine, a popular anti-malaria drug that has been used, with some success, on coronavirus patients.

Turns out, that was an outrageous distortion.

National Review reports:

The story blew up and received coverage from other liberal outlets, including the Daily Beast and Huff Post, neither of which mentioned that a Sanofi spokeswoman told the Times it no longer sells or distributes Plaquenil in the U.S. “Hydroxychloroquine” and “Sanofi” also trended throughout the day on Twitter.

But the Times failed to mention exactly how much Trump’s investment in the drug maker was worth, which Business InsiderForbes, and MarketWatch later pointed out comprises a miniscule portion of his $2.1 billion net worth.

According to Trump’s 2019 financial records, he owns between $1,000 and $15,000 in the Dodge & Cox fund, which owns approximately a 3 percent stake in Sanofi. If all three of his family trusts hold the full $15,000 in Dodge & Cox — $45,000 in total — then a 3 percent share amounts to $1,350. If, alternatively, each trust has invested the minimum $1,000 — for a total of $3,000 — the 3 percent stake is worth $90.

What the media isn’t mentioning is that Trump’s $90 stake is dwarfed by his investments in other companies. They’re also ignoring the fact that more and more doctors are saying that hydroxychloroquine is working.

What is the media’s interest in keeping that from us?

Share on facebook
Share to Facebook